This article is intended for primary care clinicians, gynecologists, endocrinologists, and other specialists who provide care to women with diabetes and possible impaired sexual function and activity.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material activity, Medscape Education Clinical Briefs, has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins September 1, 2011. Term of approval is for 1 year from this date. Each Clinical Brief is approved for .25 Prescribed credits. Credit may be claimed for 1 year from the date of each Clinical Brief. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: Total credit is subject to change based on topic selection and article length.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
AAFP Accreditation Questions
Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME/CE Released: 8/10/2012
Valid for credit through: 8/10/2013, 11:59 PM EST
processing....
Diabetes is linked with more than 3-fold increased risk for erectile dysfunction in men, according to Feldman and colleagues (J Urol. 1994;151:54-61). In 2010, Lindau and colleagues reported that diabetes could potentially affect sexual function in women through vascular changes in the urogenital tissues and neuropathy-mediated changes in arousal (Diabetes Care. 2010;33:2202-2210).
This cross-sectional cohort study by Copeland and colleagues uses data from the Reproductive Risks of Incontinence Study at Kaiser 2, described by Thom and colleagues (J Urol. 2006;175:259-264), to assess whether diabetes and end-organ complications are associated with sexual activity, desire, satisfaction, and other problems.
Sexual activity in women should be added to the list of bodily functions affected by diabetes, a new study shows.
Middle-aged women with diabetes reported lower levels of sexual desire, satisfaction, and frequency than their nondiabetic counterparts. Women with insulin-treated diabetes also reported more difficulty with lubrication, unlike women with diabetes who did not need insulin.
"These findings suggest that although many diabetic women are interested and engaged in sexual activity, diabetes is associated with a markedly decreased sexual quality of life in women either through complications of the disease itself or through use of treatments," lead author Kelli L. Copeland, BA, from the Women’s Health Clinical Research Center and the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Family and Community Medicine, and Medicine, University of California, San Francisco, and colleagues write. The study appears in the August issue of Obstetrics and Gynecology.
The participants were 2270 women aged 40 to 80 years (mean age, 55 ± 9.2 years) who participated in the Reproductive Risks of Incontinence Study at Kaiser 2, a cross-sectional cohort study of risk factors for urinary tract dysfunction in middle-aged and older women recruited from Kaiser Permanente Northern California between January 2003 and January 2008. The sample included 347 women with non-insulin-treated diabetes and 139 with insulin-treated diabetes. Sexual activity and function were assessed using the Female Sexual Function Index, which has been validated and used in other large studies of women's health. The participants also were asked about the frequency of sexual activity, including masturbation, within the previous 3 months.
Sexual activity less than once a month was reported by 82 (59%) of the women with insulin-treated diabetes and 199 (57%) of the women with non-insulin-treated diabetes compared with 839 (47%) of the 1784 nondiabetic women (P = .003 for insulin-treated compared with nondiabetic patients; P < .001 for non-insulin-treated compared with nondiabetic patients).
Of the women with insulin-treated diabetes, 83 (60%) reported low sexual desire compared with 928 (52%) of the nondiabetic women (P = .04). Low sexual desire was reported by 201 (58%) of the women with non-insulin-treated diabetes (P = .05 compared with the nondiabetic women). Similarly, 38 (27%) of the women with insulin-treated diabetes and 75 (22%) of the women with non-insulin-treated diabetes complained of low sexual satisfaction compared with 304 (17%) of the nondiabetic control patients (P < .001 and P = .009, respectively).
On multivariate analysis (with adjustments made for age; race; marital or relationship status; history of sex with men, women, or both; parity; menopausal status; body mass index; hysterectomy; oophorectomy; selective serotonin reuptake inhibitor use: and estrogen use), "the odds of reporting low overall sexual satisfaction were over twofold higher in insulin-treated diabetic women and over 40% higher in non–insulin-treated diabetic women compared with nondiabetic women," the authors write. Insulin-treated diabetic women also were more likely than nondiabetic women to confirm that their physical health limited their sexual activity "extremely" or "quite a bit" (odds ratio [OR], 2.29; 95% confidence interval [CI], 1.49 - 3.51). Diabetic women not taking insulin did not differ significantly from the women without diabetes on this measure (OR, 1.29; 95% CI, 0.92 - 1.78).
End-organ complications also were associated with diminished sexual function. Compared with diabetic women without those complications, sexual activity less than once a month was more common among women with diabetes who had heart disease (OR, 2.42; 95% CI, 1.17 - 4.98; P = .02), renal dysfunction (OR, 2.06; 95% CI, 1.16 - 3.67; P = .01), and peripheral neuropathy (OR, 1.73; 95% CI, 1.08 - 2.78; P = .02). Lower sexual desire was associated with heart disease (OR, 1.96; 95% CI, 0.99 - 3.87; P = .05) and peripheral neuropathy (OR, 1.57; 95% CI, 1.00 - 2.47; P = .05). Stroke was most strongly associated with decreased sexual satisfaction (OR, 3.32; 95% CI, 1.08 - 10.21; P = .04); however, stroke was not associated with diminished sexual activity to once or less per month, nor was stroke associated with lower sexual desire.
"This is an excellent, well-designed study," Andrea Rapkin, MD, professor of obstetrics and gynecology at the David Geffen School of Medicine at the University of California, Los Angeles, said to Medscape Medical News. "The findings are not surprising, but they are certainly important."
Dr. Rapkin was not involved in this study, but she agreed with the authors' conclusions that treatment of women with diabetes should include a sexual history and that clinicians should counsel patients that preventing end-organ complications may help preserve their sexual function.
The study was funded by grants from the National Institutes Diabetes, Digestive and Kidney Diseases (NIDDK) and the NIDDK/Office of Research on Women’s Health Specialized Center of Research. The senior author, Allison J. Huang, MD, MAS is supported by a Paul B. Beeson Career Development Award in Aging Research from the National Institute on Aging and the American Federation for Aging Research. Dr. Huang has also received research grants from Pfizer through the University of California, San Francisco, to conduct research unrelated to the study discussed in this article. The other authors and Dr. Rapkin have disclosed no relevant financial relationships.
Obstet Gynecol. 2012;120:331-340. Abstract